
    
      This is a monocenter study. 45 patients will be enrolled in the study, allocated by
      randomization in 3 arms of 15 patients each.

      During the 38 week duration of the study, enrolled patients will be assessed at:

        -  initial evaluation (first week of the study),

        -  intermediary evaluation for every week and every modification of intensity of pain,

        -  final evaluation at 10 weeks,

        -  follow-up evaluation at 6 months.
    
  